Innovation Hub

The latest breakthroughs, technologies, and resources organized across every stage in the drug development lifecycle.

Featured

The Fit-for-Purpose Gap: What RWD Still Gets Wrong

In this session, industry experts Dr. Radek Wasiak and Isabella Even-Chen break down the critical "Fit-for-Purpose Gap"—the misstep of assuming a single, generalized dataset can satisfy every study design, regulatory requirement, or health economics endpoint.

Highlight

Webinar

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Webinar

Engineering Neuromodulation for Cardiovascular Instability

Upcoming Webinars

From the Blog

Browse by Stage

Discovery & Preclinical

Supporting early-stage research with the tools and expertise to move from hypothesis to candidate.

+ More

Clinical

Resources spanning Phase I–III, from trial design to patient recruitment and data management.

Biometrics

Clinical Trials

Trial Insights

+ More

Pharmaceutical Development & Manufacturing

Insights across formulation, scale-up, and GMP manufacturing.

Chemical & Compound Analysis

Discovery Chemistry

+ More

Medical & Commercial

Guidance on market access, medical affairs, and commercialization strategy.

Medical Communications

Discovery Chemistry

+ More

Podcasts

Podcast

ShareSci

#ShareScience is a podcast by InsideScientific, the online environment for Life Science webinars, virtual events, interviews and educational content that helps you do your best work.

Podcast

tHEORetically Speaking

Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care.

Podcast

#ExpertAnswers

#ExpertAnswers is a podcast by InsideScientific, the online environment for Life Science webinars, virtual events, interviews and educational content that helps you do your best work.

Innovation Hub

The Fit-for-Purpose Gap: What RWD Still Gets Wrong

Heading

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Engineering Neuromodulation for Cardiovascular Instability

Engineering Neuromodulation for Cardiovascular Instability

A More Complete Picture of Antibody Function: Lessons from Comprehensive Fc Profiling of Approved Anti-CD20 Antibodies

Engineering Neuromodulation for Cardiovascular Instability

Measuring Target Protein Degradation in PBMCs: A KIF22 Pharmacodynamic Biomarker for the Clinic

The Fit-for-Purpose Gap: What RWD Still Gets Wrong

Biomarkers Before the Assay: Sample Strategy and Signal Integrity

Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk

Upcoming Webinars

The latest from the Innovation Hub, straight to your inbox.

What Experimental Data Do AI-Designed Antibodies Need?

The Evolving Landscape of Drug Discovery for Metabolic Diseases

June 2026 Medical/Commercial Pulse Check

Accelerating the Design–Build–Test–Learn Cycle for AI-Driven Antibody Discovery

Screening the Unscreenable: How Physics-Grounded AI Is Expanding the Reach of Drug Discovery

Reducing risk in CRO studies: Choosing the right cell models for outsourced research

Cutting Months Off AAV Programs: The Synthetic DNA Shift

Speed Matters: Why RWE Acceleration Starts Upstream with Reusable Data

Industry Insights: Behind the Scenes of BPS Bioscience Custom R&D

Comprehensive Plasma cell-free RNA Profiling for Superior Cancer Detection

Advanced Screening Strategies for Molecular Glue Discovery

AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation

Supplier Spotlight: RadMD Imaging

AI Is Expanding What's Possible in Drug Discovery. Operational Friction Still Determines How Fast It Happens.

The Science of the "Gut Feeling": Why Techs are a Lab's Best Diagnostic Tool

Supplier Spotlight: MedChemExpress

HealthEconomics.com 2026 Pulse Check – March

Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing

2026 PharmDev Roadmap: The Regulatory Shift

Five Reasons Leading CNS Programs Rely on BrainXell for Custom iPSC Models

From the Colony to the Roadmap: The FDA's New Stance on NAMs and Why it Matters

2026 PharmDev Roadmap: The Strategic Partner

2026 PharmDev Roadmap: The Predictive Model

2026 PharmDev Roadmap: The Complexity Spike

Explore FUJIFILM's Cyclic Peptide Discovery Service

2026 PharmDev Roadmap: The Resilience Pivot

The Biosecure Act: Navigating Changes in the Biopharma Supply Chain

Evolving Frontiers in Immunohistochemistry: Applications and Transformations in Modern Biotechnology

Supplier Spotlight: Shuimu Biosciences

Beyond the Bead: 10 Questions on How to Improve the Reliability of Flow Cytometry Controls with Precision-Engineered Cell Mimics

From the Blog

Browse by Stage

Discovery & Preclinical

Clinical

Pharmaceutical Development & Manufacturing

Medical & Commercial

Podcasts

ShareSci

tHEORetically Speaking

#ExpertAnswers

INsights & OUTcomes with Renée Arnold

From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap

Talking Real Science with Stella Goulopoulou

Talking Real Science with Yelena Akelina

#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8+ T Cell Co-culture Experiments

Talking Real Science with Licy Yanes Cardozo

Industry Insights with Bas Trietsch and STEMCELL Technologies

Talking Real Science with Helen Collins

Talking Real Science with Rachel Buckley

Talking Real Science with Meaghan Loy on Rare Disease Day

Other podcasts

The Digital Backbone for Modern Life Sciences